Hormonal and cognitive factors associated with the exploratory behavior of rats submitted to repeated sessions of the elevated plus-maze

Psychology and Neuroscience

Volumn 3, Issue 1, 2010, Pages

  Albrechet Souza, Lucas ^a   Brandão, Marcus L ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anterior cingulate cortex; Benzodiazepines; Corticosterone; Elevated plus maze; Fos expression; Retest session

Indexed keywords

CORTICOTROPIN; MIDAZOLAM; PROTEIN FOS;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ARTICLE; BRAIN MAPPING; BRAIN STEM; CINGULATE GYRUS; COGNITION; EXPLORATORY BEHAVIOR; HORMONE RELEASE; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAZE TEST; NERVE CELL; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PREFRONTAL CORTEX; PROTEIN EXPRESSION; RAT; TELENCEPHALON;

EID: 77954553886     PISSN: 19843054     EISSN: 19833288     Source Type: Journal    
DOI: 10.3922/j.psns.2010.1.005     Document Type: Article

References (84)

1. Albrechet-Souza, L., Borelli, K.G., & Brandão, M.L. (2008). Activity of the medial prefrontal cortex and amygdala underlies one-trial tolerance of rats in the elevated plus-maze. Journal of Neuroscience Methods, 169, 109-118.
2. Albrechet-Souza, L., Borelli, K.G., Carvalho, M.C., & Brandão, M.L. (2009). The anterior cingulate cortex is a target structure for the anxiolytic-like effects of benzodiazepines assessed by repeated exposure to the elevated plus-maze and fos immunoreactivity. Neuroscience, 164, 387-397.
3. Albrechet-Souza, L., Carvalho, M.C., Franci, C.R., & Brandão, M.L. (2007). Increases in plasma corticosterone and stretched-attend postures in rats naive and previously exposed to the elevated plus-maze are sensitive to the anxiolytic-like effects of midazolam. Hormones and Behavior, 52, 267-273.
4. Albrechet-Souza, L., Oliveira, A.R., De Luca, M.C.Z., Tomazini, F., Santos, N.R., & Brandão, M.L. (2005). A comparative study with two types of elevated plus-maze (transparent vs. opaque walls) on the anxiolytic effects of midazolam, one-trial tolerance and fear-induced analgesia. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 29, 571-579.
5. Anderson, R.A., & Mitchell, R. (1994). Analysis of benzodiazepine binding sites in rat pituitary gland. Brain Research, 323, 369-373.
6. Anseloni, V.C.Z., & Brandão, M.L. (1997). Ethopharmacological analysis of behaviour of rats using variations of the elevated plus-maze. Behavioral Pharmacology, 8, 533-540.
7. Avanzi, V., & Brandão, M.L. (2001). Activation of somatodrendritic 5-HT1A autoreceptors in the raphe nucleus disrupts the contextual conditioning in rats. Behavioural Brain Research, 126, 175-184.
8. Avanzi, V., Castilho, V.M., Andrade, T.G.C., & Brandão, M.L. (1998). Regulation of contextual conditioning by the median raphe nucleus. Brain Research, 790, 178-184.
9. Barbalho, C.A., Canto-de-Souza, A.L., & Nunes-de-Souza, R.L. (2009). Similar anxiolytic-like effects following intra-amygdala infusions of benzodiazepine receptor agonist and antagonist: evidence for the release of an endogenous benzodiazepine inverse agonist in mice exposed to elevated plus-maze test. Brain Research, 1267, 65-76.
10. Bernardis, L.L., & Bellinger, L.L. (1987). The dorsomedial hypothalamic nucleus revisited: 1986 update. Brain Research, 434, 321-381.
11. Bertoglio, L.J., Anzini, C., Lino-de-Oliveira, C., & Carobrez, A.P. (2005). Enhanced dorsolateral periaqueductal gray activity counteracts the anxiolytic response to midazolam on the elevated plus-maze Trial 2 in rats. Behavioural Brain Research, 162, 99-107.
12. Bertoglio, L.J., & Carobrez, A.P. (2000). Previous maze experience required to increase open arms avoidance in rats submitted to the elevated plus-maze model of anxiety. Behavioural Brain Research, 108, 197-203.
13. Bertoglio, L.J., & Carobrez A.P. (2002). Prior maze experience required to alter midazolam effects in rats submitted to the elevated plus-maze. Pharmacology, Biochemistry and Behavior, 72, 449-455.
14. Bertoglio, L.J., & Carobrez A.P. (2003). Anxiolytic-like effects of NMDA/glycine-B receptor ligands are abolished during the elevated plus-maze Trial 2 in rats. Psychopharmacology, 170, 335-342.
15. Bertoglio, L.J., & Carobrez A.P. (2004). Scopolamine given pre-Trial 1 prevents the one-trial tolerance phenomenon in the elevated plus-maze Trial 2. Behavioural Pharmacology, 15, 45-54.
16. Blanchard, D.C., Blanchard, R.J., & Rodgers, R.J. (1991). Risk assessment and animal models of anxiety. In B. Olivier, J. Mos, & J.L. Slangen (Eds), Animal models in Psychopharmacology (pp. 117-134). Basel: Birkauser.
17. Blanchard, R.J., Yudko, E.B., Rodgers, R.J., & Blanchard, D.C. (1993). Defense system psychopharmacology: an ethological approach to the pharmacology of fear and anxiety. Behavioural Brain Research, 58, 155-165.
18. Borelli, K.G., & Brandão, M.L. (2008). Effects of ovine CRF injections into the dorsomedial, dorsolateral and lateral columns of the periaqueductal gray: a functional role for the dorsomedial column. Hormones and Behavior, 53, 40-50.
19. Brown, C., & Martin, I.L. (1984). Autoradiographic localization of benzodiazepine receptors in the rat anterior pituitary gland. European Journal of Pharmacology, 102, 563-564.
20. Canteras, N.S. (2002). The medial hypothalamic defensive system: hodological organization and functional implications. Pharmacology, Biochemistry and Behavior, 71, 481-491.
21. Canteras, N.S., Chiavegatto, S., Ribeiro do Valle, L.E., & Swanson, L.W. (1997). Severe reduction of defensive behavior to a predator by discrete hypothalamic chemical lesions. Brain Research Bulletin, 44, 297-305.
22. Carobrez, A.P., & Bertoglio, L.J. (2005). Ethological and temporal analyses of anxiety- like behavior: the elevated plus-maze model 20 years on. Neuroscience and Biobehavioral Reviews, 29, 1193-1205.
23. Carvalho, M.C., Albrechet-Souza, L., Masson, S., & Brandão, M.L. (2005). Changes in the biogenic amine content of the prefrontal cortex, amygdala, dorsal hippocampus, and nucleus accumbens of rats submitted to single and repeated sessions of the elevated plus-maze test. Brazilian Journal of Medical and Biological Research, 38, 1857-1866.
24. Chan, R.K.W., Brown, E.R., Ericsson, A., Kovacs, K.J., & Sawchenko, P.E. (1993). A comparison of two immediate early genes, c-fos and NGFI-B, as markers for functional activation in stress-related neuroendocrine circuitry. The Journal of Neuroscience, 13, 5126-5138.
25. Cole, J.C., & Rodgers, R.J. (1993). An ethological analysis of chlordiazepoxide and bretazenil (Ro16-6028) in the murine elevated plus-maze. Behavioral Pharmacology, 4, 573-580.
26. Comoli, E., Ribeiro-Barbosa, E.R., & Canteras, N.S. (2000). Afferent connections of the dorsal premammillary nucleus. Journal of Comparative Neurology, 423, 83-98.
27. Cruz-Morales, S.E., Santos, N.R., & Brandão, M.L. (2002). One-trial tolerance to midazolam is due to enhancement of fear and reduction of anxiolytic-sensitive behaviors in the elevated plus-maze retest in the rat. Pharmacology, Biochemistry and Behavior, 72, 973-978.
28. Dal-Cól, L., Orlandi-Pereira, V.P., Rosa, A.V., Calixto, A.P., Carobrez, A.P., & Faria M.S. (2003). Lack of midazolam-induced anxiolysis in the plus-maze Trial 2 is dependent on the length of Trial 1. Pharmacology, Biochemistry and Behavior, 74, 395-400.
29. Dawson, G.R., Crawford, S.P., Stanhope, K.J., Iversen, S.D., & Tricklebank, M.D. (1994). One-trial tolerance to the effects of chlordiazepoxide on the elevated plus- maze may be due to locomotor habituation, not repeated drug exposure. Psychopharmacology, 113, 570-572.
30. De Quervain, D.J.F., Roozendaal, B., & McGaugh, J.L. (1998). Stress and glucocorticoids impair retrieval of long-term spatial memory. Nature 394, 787-790.
31. De Souza, E.B., Anholt, R.R.H., Murphy, K.M.M., Snyder, S.H., & Kuhar, M.K. (1985). Peripheral-type benzodiazepine receptors in endocrine organs: autoradiographic localization in rat pituitary, adrenal and testis. Endocrinology, 116, 567-573.
32. Devinsky, O., Morrell, M.J., & Vogt, B.A. (1995). Contributions of anterior cingulate cortex to behaviour. Brain, 118, 279-306.
33. File, S.E. (1990). One-trial tolerance to the anxiolytic effects of chlordiazepoxide in the plus-maze. Psychopharmacology, 100, 281-282.
34. File, S.E. (1993). The interplay of learning and anxiety in the elevated plus-maze. Behavioural Brain Research, 58, 199-202.
35. File, S.E., Gonzalez, L.E., & Gallant, R. (1999). Role of the dorsomedial hypothalamus in mediating the response to benzodiazepines on trial 2 in the elevated plus-maze test of anxiety. Neuropsychopharmacology, 21, 312-320.
36. File, S.E., Mabutt, P.S., & Hitchott, P.K. (1990). Characterization of the phenomenon of 'one-trial tolerance' to the anxiolytic effects of chlordiazepoxide in the elevated plus- maze. Psychopharmacology, 102, 91-101.
37. File, S.E., Zangrossi, H., Sanders, F.L., & Mabbutt, P.S. (1994). Raised corticosterone in the rat after exposure to the elevated plus-maze. Psychopharmacology, 113, 543-546.
38. File S.E., Zangrossi, H., Viana, M., & Graeff, F.G. (1993). Trial 2 in the elevated plus- maze: a different form of fear? Psychopharmacology, 111, 491-494.
39. Gonzalez, L.E., & File, S.E. (1997). A five-minute experience in the elevated plus-maze alters the state of the benzodiazepine receptor in the dorsal raphe nucleus. The Journal of Neuroscience, 17, 1505-1511.
40. Griebel, G., Rodgers, R.J., Perrault, G., & Sanger, D.J. (1997). Risk assessment behaviour: evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze test. Pharmacology, Biochemistry and Behavior, 57, 817-827.
41. Handley, S.L., & Mithani, S. (1984). Effects of alpha-adrenoreceptor agonist in a maze- exploration model of "fear-motivated behaviour". Naunyn-Scmiedeberg's Archives of Pharmacology, 327, 1-5.
42. Heidbreder, C.A., & Groenewegen, H.J. (2003). The medial prefrontal cortex in the rat: evidence for a dorso-ventral distinction based upon functional and anatomical characteristics. Neuroscience and Biobehavioral Reviews, 27, 555-579.
43. Holmes, A., & Rodgers, R. J. (1998). Responses of Swiss-Webster mice to repeated plus-maze as experience: further evidence for qualitative shift in emotional state. Pharmacology, Biochemistry and Behavior, 60, 473-488.
44. Holschneider, D.P., Yang, J., Sadler, T.R., Nguyen, P.T., Givrad, T.K., & Maarek, J.M.I. (2006). Mapping cerebral blood flow changes during auditory-cued conditioned fear in the nontethered, nonrestrained rat. Neuroimage, 29, 1344-1358.
45. Imaki, T., Wang, X.Q., Shibasaki, T., Harada, S., Chikada, N., Takahashi, C., Naruse, M., & Demura, H. (1995). Chlordiazepoxide attenuates stress-induced activation of neurons, corticotropin-releasing factor (CRF) gene transcription and CRF biosynthesis in the paraventricular nucleus (PVN). Molecular Brain Research, 32, 261-270.
46. Keim, S.R., & Shekhar, A. (1996). The effects of GABAA receptor blockade in the dorsomedial hypothalamic nucleus on corticotrophin (ACTH) and corticosterone secretion in male rats. Brain Research, 739, 46-51.
47. LeDoux, J.E., Iwata, J., Cicchetti, P., & Reis, D.J. (1988). Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear. The Journal of Neuroscience, 8, 2517-2529.
48. Lister, R.G. (1987). The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology, 92, 180-185.
49. Maier, S.F., Kalman, B.A., & Grahn, R.E. (1994). Chlordiazepoxide microinjected into the region of the dorsal raphe nucleus eliminates the interference with escape responding produced by inescapable shock whether administered before inescapable shock or escape testing. Behavioural Neuroscience, 108, 121-130.
50. Maren, S. (2008). Pavlovian fear conditioning as a behavioral assay for hippocampus and amygdala function: cautions and caveats. European Journal of Neuroscience, 28, 1661-1666.
51. Mason, W. (1968). "Over-all" hormonal balance as a key to endocrine organization. Psychosomatic Medicine 30, 791-808.
52. Mikics, E., Barsy, B., Barsvari, B., & Haller, J. (2005). Behavioral specificity of non- genomic glucocorticoid effects in rats: effects on risk assessment in the elevated plus-maze and the open-field. Hormones and Behavior, 48, 152-162.
53. Milad, M.R., & Quirk, G.J. (2002). Neurons in medial prefrontal cortex signal memory for fear extinction. Nature, 420, 70-74.
54. Mobbs, D., Petrovic, P., Marchant, J.L., Hassabis, D., Weiskopf, N., Seymour, B., Dolan, R.J., & Frith, C.D. (2007). When fear is near: threat imminence elicits prefrontal-periaqueductal gray shifts in humans. Science, 317, 1079-1083.
55. Morgan, M. A., Romanski, L. M., & LeDoux, J. E. (1993). Extinction of emotional learning: Contribution of medial prefrontal cortex. Neuroscience Letters, 163, 109-113.
56. Morgan, M.A., & LeDoux, J.E. (1995). Differential contribution of dorsal and ventral medial prefrontal cortex to the acquisition and extinction of conditioned fear in rats. Behavioral Neuroscience, 109, 681-688.
57. Paré, D., Quirk, G.J., & Ledoux, J.E. (2004). New vistas on amygdala networks in conditioned fear. Journal of Neurophysiology, 92, 1-9.
58. Parent, A., Descarries, L., & Beaudet, A. (1981). Organization of ascending serotonin systems in the adult rat brain. A radioautographic study after intraventricular administration of [3H]5-hydroxytryptamine. Neuroscience, 6, 115-138.
59. Paxinos, G., & Watson, C. (2005). The rat brain in stereotaxic coordinates. San Diego: Elsevier Academic Press.
60. Pellow, S., Chopin, P., File, S.E., & Briley, M. (1985). Validation of open-closed arm entries in the elevated plus-maze as a measure of anxiety in the rat. Journal of Neuroscience Methods, 14, 149-167.
61. Pereira, J.K.D., Vieira, R.J., Konishi, C.T., Ribeiro, R.A., & Frussa-Filho, R. (1999). The phenomenon of 'one-trial tolerance' to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze is abolished by the introduction of a motivational conflict situation. Life Science, 65, 101-107.
62. Pezze, M.A., Bast, T., & Feldon, J. (2003). Significance of dopamine transmission in the rat medial prefrontal cortex for conditioned fear. Cerebral Cortex, 13, 371-380.
63. Reis, L.M., & Canto-de-Souza, A. (2008). Intra-periaqueductal gray matter injections of midazolam fail to alter anxiety in plus-maze experienced mice. Brain Research, 1231, 93-102.
64. Risbrough, B., & Stein, M.B. (2006). Role of corticotropin-releasing factor in anxiety disorders: a translational research perspective. Hormones and Behavior, 50, 550-561.
65. Rivier, C.L., Grigoriadis, D.E., & Rivier, J.E. (2003). Role of corticotropin-releasing factor receptors type 1 and 2 in modulating the rat adrenocorticotropin response to stressors. Endocrinology, 144, 2396-2403.
66. Rodgers, R.J. (1997). Animal models of 'anxiety': where next? Behavioral Pharmacology, 8, 477-496.
67. Rodgers, R.J., Cao, B.J., Dalvi, A., & Holmes, A. (1997). Animal models of anxiety: an ethological perspective. Brazilian Journal of Medical and Biological Research, 30, 289-304.
68. Rodgers, R.J., & Cole, J.C. (1994). The elevated plus-maze: pharmacology, methodology and ethology. In S.J. Cooper, & C.A. Hendrie (Eds), Ethology and Psychopharmacology (pp. 9-44). Wiley: Chichester.
69. Rodgers, R.J., Haller, J., Holmes, A., Halasz, J., Walton, T.J., & Brain, P.F. (1999). Corticosterone response to the plus-maze: high correlation with risk assessment in rats and mice. Physiology and Behavior, 68, 47-53.
70. Rodgers, R.J., & Johnson, J.T. (1995). Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacology, Biochemistry and Behavior, 52, 297-303.
71. Roozendaal, B., Bohus, B., & McGaugh, J.L. (1996). Dose-dependent suppression of adrenocortical activity with metyrapone: Effects on emotion and memory. Psychoneuroendcocrinology, 21, 681-693.
72. Setem, J., Pinheiro, A.P., Motta, V.A., Morato, S., & Cruz, A.P.M. (1999). Ethopharmacological analysis of 5-HT ligands on the rat elevated plus-maze. Pharmacology, Biochemistry and Behavior, 62, 515-521.
73. Shah, A.A., & Treit, D. (2004). Infusions of midazolam into the medial prefrontal cortex produce anxiolytic effects in the elevated plus-maze and shock-probe burying tests. Brain Research, 996, 31-40.
74. Siegel, A., & Chabora, J. (1971). Effects of electrical stimulation of the cingulate gyrus upon attack behavior elicited from the hypothalamus in the rat. Brain Research, 32, 169-177.
75. Siegel, A., Edinger, H., & Lowenthal, H. (1974). Effects of electrical stimulation of the medial aspect of the prefrontal cortex upon attack behavior in cats. Brain Research, 66, 467-479.
76. Sierra-Mercado, D.J., Corcoran, K.A., Lebron-Milad, K., & Quirk, G.J. (2006). Inactivation of the ventromedial prefrontal cortex reduces expression of conditioned fear and impairs subsequent recall of extinction. European Journal of Neuroscience, 24, 1751-1758.
77. Silveira, M.C., Sandner, G., & Graeff, F.G. (1993). Induction of Fos immunoreactivity in the brain by exposure to the elevated plus-maze. Behavioural Brain Research, 56, 115-118.
78. Singewald, N. (2007). Altered brain activity processing in high-anxiety rodents revealed by challenge paradigms and functional mapping. Neuroscience and Biobehavioral Reviews, 31, 18-40.
79. Stern, C.A., Carobrez, A.P., & Bertoglio, J.L. (2008). Aversive learning as a mechanism for lack of repeated anxiolytic-like effect in the elevated plus-maze. Pharmacology, Biochemistry and Behavior, 90, 545-550.
80. Treit, D., Menard, J., & Royan, C. (1993). Anxiogenic stimuli in the elevated plus- maze. Pharmacology, Biochemistry and Behavior, 44, 463-469.
81. Vale, W.W., Spiess, J., Rivier C., & Rivier, J. (1981). Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta- endorphin. Science, 18, 1394-1397.
82. Vouimba, R.M., Garcia, R., Baudry, M., & Thompson, R.F. (2000). Potentiation of conditioned freezing following dorsomedial prefrontal cortex lesions does not interfere with fear reduction in mice. Behavioral Neuroscience, 114, 720-724.
83. Yang, M., Farrokhi, C., Vasconcellos, A., Blanchard, R.J., & Blanchard, D.C. (2006). Central infusion of ovine CRF (oCRF) potentiates defensive behaviors in CD-1 mice in the Mouse Defense Test Battery (MDTB). Behavioural Brain Research, 17, 1-8.
84. Zanoveli, J.M., Ferreira-Netto, C., & Brandão, M.L. (2007). Conditioned place aversion organized in the dorsal periaqueductal gray recruits the laterodorsal nucleus of thalamus and basolateral amygdala. Experimental Neurology, 208, 127-136.